{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:59:57Z","timestamp":1789660797198,"version":"4.0.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1093\/humrep\/15.6.1266","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:22:29Z","timestamp":1027722149000},"page":"1266-1274","source":"Crossref","is-referenced-by-count":152,"title":["Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome"],"prefix":"10.1093","volume":"15","author":[{"given":"Laure C.","family":"Morin-Papunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Vauhkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta M.","family":"Koivunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimo","family":"Ruokonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha S.","family":"Tapanainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,6]]},"reference":[{"key":"key\n\t\t\t\t20170410034031_ACIEN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Acien, P., Quereda, F., Matallin, P. et al. (1999) Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil. Steril., 71, 32\u201340.","DOI":"10.1016\/S0015-0282(99)00184-3"},{"key":"key\n\t\t\t\t20170410034031_ANONYMOUS-1997","doi-asserted-by":"crossref","unstructured":"Anonymous (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus [see comments]. Diabetes Care, 20, 1183\u20131197.","DOI":"10.2337\/diacare.20.7.1183"},{"key":"key\n\t\t\t\t20170410034031_BAKER-ETAL-1984","doi-asserted-by":"crossref","unstructured":"Baker, B., Mandarino, L., Brick, B. et al. (1984) Influence of changes in insulin receptor binding during insulin infusions on the shape of the insulin dose\u2013response curve for glucose disposal in man. J. Clin. Endocrinol. Metab., 58, 392\u2013396.","DOI":"10.1210\/jcem-58-2-392"},{"key":"key\n\t\t\t\t20170410034031_BJORNTORP-1997","doi-asserted-by":"crossref","unstructured":"Bjo\u0308rntorp, P. (1997) Body fat distribution, insulin resistance, and metabolic diseases. Nutrition, 13, 795\u2013803.","DOI":"10.1016\/S0899-9007(97)00191-3"},{"key":"key\n\t\t\t\t20170410034031_BRINGER-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Bringer, J., Lefebvre, P., Boulet, F. et al. (1993) Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles. Ann. NY Acad. Sci., 687, 115\u2013123.","DOI":"10.1111\/j.1749-6632.1993.tb43860.x"},{"key":"key\n\t\t\t\t20170410034031_CAMPBELL-AND-GERICH-1990","doi-asserted-by":"crossref","unstructured":"Campbell, P.J. and Gerich, J.E. (1990) Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. J. Clin. Endocrinol. Metab., 70, 1114\u20131118.","DOI":"10.1210\/jcem-70-4-1114"},{"key":"key\n\t\t\t\t20170410034031_CHANG-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Chang, R.J., Nakamura, R.M., Judd, H.L. et al. (1983) Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 57, 356\u2013359.","DOI":"10.1210\/jcem-57-2-356"},{"key":"key\n\t\t\t\t20170410034031_CIAMPELLI-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Ciampelli, M., Fulghesu, A.M., Cucinelli, F. et al. (1997) Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum. Reprod., 12, 1897\u20131901.","DOI":"10.1093\/humrep\/12.9.1897"},{"key":"key\n\t\t\t\t20170410034031_CIARALDI-ETAL-1992","unstructured":"Ciaraldi, T.P., El-Roeiy, A., Madar, Z. et al. (1992) Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J. Clin. Endocrinol. Metab., 75, 577\u2013583."},{"key":"key\n\t\t\t\t20170410034031_COOK-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Cook, D., Godsland, I.F., Hull, J. et al. (1997) Hormone replacement therapy with dydrogesterone and 17 b-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. Br. J. Obstet. Gynaecol., 104, 298\u2013304.","DOI":"10.1111\/j.1471-0528.1997.tb11457.x"},{"key":"key\n\t\t\t\t20170410034031_DAHLGREN-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Dahlgren, E., Janson, P.O., Johansson, S. et al. (1992) Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet. Gynecol. Scand., 71, 599\u2013604.","DOI":"10.3109\/00016349209006227"},{"key":"key\n\t\t\t\t20170410034031_DEFRONZO-ETAL-1979","doi-asserted-by":"crossref","unstructured":"DeFronzo, R.A., Tobin, J.D. and Andres, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol., 237, E214\u2013223.","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"key":"key\n\t\t\t\t20170410034031_DUNAIF-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Graf, M., Mandeli, J. et al. (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia. J. Clin. Endocrinol. Metab., 65, 499\u2013507.","DOI":"10.1210\/jcem-65-3-499"},{"key":"key\n\t\t\t\t20170410034031_DUNAIF-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Segal, K.R., Futterweit, W. et al. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165\u20131174.","DOI":"10.2337\/diab.38.9.1165"},{"key":"key\n\t\t\t\t20170410034031_DUNAIF-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Segal, K.R., Shelley, D.R. et al. (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes, 41, 1257\u20131266.","DOI":"10.2337\/diab.41.10.1257"},{"key":"key\n\t\t\t\t20170410034031_DUNAIF-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Xia, J., Book, C.B. et al. (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest., 96, 801\u2013810.","DOI":"10.1172\/JCI118126"},{"key":"key\n\t\t\t\t20170410034031_EHRMANN-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Ehrmann, D.A., Sturis, J., Byrne, M.M. et al. (1995) Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J. Clin. Invest., 96, 520\u2013527.","DOI":"10.1172\/JCI118064"},{"key":"key\n\t\t\t\t20170410034031_EHRMANN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Ehrmann, D.A., Barnes, R.B., Rosenfield R.L. et al. (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care, 22, 141\u2013146.","DOI":"10.2337\/diacare.22.1.141"},{"key":"key\n\t\t\t\t20170410034031_FABER-ETAL-1978","doi-asserted-by":"crossref","unstructured":"Faber, O.K., Hagen, C., Binder, C. et al. (1978) Kinetics of human connecting peptide in normal and diabetic subjects. J. Clin. Invest., 62, 197\u2013203.","DOI":"10.1172\/JCI109106"},{"key":"key\n\t\t\t\t20170410034031_FERRANNINI-1988","doi-asserted-by":"crossref","unstructured":"Ferrannini, E. (1988) The theoretical bases of indirect calorimetry: a review. Metab. Clin. Exp., 37, 287\u2013301.","DOI":"10.1016\/0026-0495(88)90110-2"},{"key":"key\n\t\t\t\t20170410034031_FERRANNINI-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Ferrannini, E., Barrett, E.J., Bevilacqua, S. et al. (1983) Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest., 72, 1737\u20131747.","DOI":"10.1172\/JCI111133"},{"key":"key\n\t\t\t\t20170410034031_FERRIMAN-AND-GALLWEY-1961","doi-asserted-by":"crossref","unstructured":"Ferriman, D. and Gallwey, J.D. (1961) Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab., 21, 1440\u20131447.","DOI":"10.1210\/jcem-21-11-1440"},{"key":"key\n\t\t\t\t20170410034031_GRAY-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Gray, A., Feldman, H.A., McKinlay, J.B. et al. (1991) Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab., 73, 1016\u20131025.","DOI":"10.1210\/jcem-73-5-1016"},{"key":"key\n\t\t\t\t20170410034031_HAMMAMI-AND-SIITERI-1991","doi-asserted-by":"crossref","unstructured":"Hammami, M.M. and Siiteri, P.K. (1991) Regulation of 11b-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J. Clin. Endocrinol. Metab., 73, 326\u2013334.","DOI":"10.1210\/jcem-73-2-326"},{"key":"key\n\t\t\t\t20170410034031_HOLMANG-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Holmang, A., Svedberg, J., Jennische, E. et al. (1990) Effects of testosterone on muscle insulin sensitivity and morphology in female rats. Am. J. Physiol., 259, E555\u2013560.","DOI":"10.1152\/ajpendo.1990.259.4.E555"},{"key":"key\n\t\t\t\t20170410034031_HOLTE-ETAL-1994A","doi-asserted-by":"crossref","unstructured":"Holte, J., Bergh, T., Berne, C. et al. (1994a) Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J. Clin. Endocrinol. Metab., 78, 1052\u20131058.","DOI":"10.1210\/jcem.78.5.8175959"},{"key":"key\n\t\t\t\t20170410034031_HOLTE-ETAL-1994B","doi-asserted-by":"crossref","unstructured":"Holte, J., Bergh, T., Berne, C. et al. (1994b) Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin. Endocrinol., 41, 463\u2013471.","DOI":"10.1111\/j.1365-2265.1994.tb02577.x"},{"key":"key\n\t\t\t\t20170410034031_HOLTE-ETAL-1995","unstructured":"Holte, J., Bergh, T., Berne, C. et al. (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 80, 2586\u20132593."},{"key":"key\n\t\t\t\t20170410034031_HOMBURG-1996","doi-asserted-by":"crossref","unstructured":"Homburg, R. (1996) Polycystic ovary syndrome\u2014from gynaecological curiosity to multisystem endocrinopathy. Hum. Reprod., 11, 29\u201339.","DOI":"10.1093\/oxfordjournals.humrep.a019031"},{"key":"key\n\t\t\t\t20170410034031_INSEL-ETAL-1980","doi-asserted-by":"crossref","unstructured":"Insel, J.R., Kolterman, O.G., Saekow, M. et al. (1980) Short-term regulation of insulin receptor affinity in man. Diabetes, 29, 132\u2013139.","DOI":"10.2337\/diab.29.2.132"},{"key":"key\n\t\t\t\t20170410034031_KOSAKA-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Kosaka, K., Kuzuya, T., Hagura, R. et al. (1996) Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet. Med., 13, S109\u2013119.","DOI":"10.1002\/dme.1996.13.s6.109"},{"key":"key\n\t\t\t\t20170410034031_LAAKSO-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Laakso, M., Uusitupa, M., Takala, J. et al. (1988) Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycaemia in obese non-insulin-dependent diabetic subjects. Metab. Clin. Exp., 37, 1092\u20131100.","DOI":"10.1016\/0026-0495(88)90074-1"},{"key":"key\n\t\t\t\t20170410034031_MANDARINO-ETAL-1984","doi-asserted-by":"crossref","unstructured":"Mandarino, L., Baker, B., Rizza, R. et al. (1984) Infusion of insulin impairs human adipocyte glucose metabolism in vitro without decreasing adipocyte insulin receptor binding. Diabetologia, 27, 358\u2013363.","DOI":"10.1007\/BF00304850"},{"key":"key\n\t\t\t\t20170410034031_MARTIKAINEN-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Martikainen, H., Salmela, P., Nuojua-Huttunen, S. et al. (1996) Adrenal steroidogenesis is related to insulin in hyperandrogenic women. Fertil. Steril., 66, 564\u2013570.","DOI":"10.1016\/S0015-0282(16)58568-9"},{"key":"key\n\t\t\t\t20170410034031_MCKENNA-AND-CUNNINGHAM-1995","doi-asserted-by":"crossref","unstructured":"McKenna, T.J. and Cunningham, S.K. (1995) Adrenal androgen production in polycystic ovary syndrome. Eur. J. Endocrinol., 133, 383\u2013389.","DOI":"10.1530\/eje.0.1330383"},{"key":"key\n\t\t\t\t20170410034031_MOGHETTI-ETAL-1996","unstructured":"Moghetti, P., Castello, R., Negri, C. et al. (1996) Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J. Clin. Endocrinol. Metab., 81, 881\u2013886."},{"key":"key\n\t\t\t\t20170410034031_MORALES-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Morales, A.J., Laughlin, G.A., Butzow, T. et al. (1996) Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J. Clin. Endocrinol. Metab., 81, 2854\u20132864.","DOI":"10.1210\/jc.81.8.2854"},{"key":"key\n\t\t\t\t20170410034031_NANKERVIS-ETAL-1985","doi-asserted-by":"crossref","unstructured":"Nankervis, A., Proietto, J., Aitken, P. et al. (1985) Hyperinsulinaemia and insulin insensitivity: studies in subjects with insulinoma. Diabetologia, 28, 427\u2013431.","DOI":"10.1007\/BF00280885"},{"key":"key\n\t\t\t\t20170410034031_OVESEN-ETAL-1993","unstructured":"Ovesen, P., Moller, J., Ingerslev, H.J. et al. (1993) Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 77, 1636\u20131640."},{"key":"key\n\t\t\t\t20170410034031_PEIRIS-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Peiris, A.N., Aiman, E.J., Drucker, W.D. et al. (1989) The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women. J. Clin. Endocrinol. Metab., 68, 715\u2013720.","DOI":"10.1210\/jcem-68-4-715"},{"key":"key\n\t\t\t\t20170410034031_PLYMATE-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Plymate, S.R., Matej, L.A., Jones, R.E. et al. (1988) Inhibition of sex hormone-binding globulin in the hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab., 67, 460\u2013464.","DOI":"10.1210\/jcem-67-3-460"},{"key":"key\n\t\t\t\t20170410034031_POLDERMAN-ETAL-1994","unstructured":"Polderman, K.H., Gooren, L.J., Asscheman, H. et al. (1994) Induction of insulin resistance by androgens and estrogens. J. Clin. Endocrinol. Metab., 79, 265\u2013271."},{"key":"key\n\t\t\t\t20170410034031_POLONSKY-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Polonsky, K., Jaspan, J., Pugh, W. et al. (1983) Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J. Clin. Invest., 72, 1114\u20131123.","DOI":"10.1172\/JCI111036"},{"key":"key\n\t\t\t\t20170410034031_RANDLE-ETAL-1963","doi-asserted-by":"crossref","unstructured":"Randle, R., Hales, C., Garlandy, P. et al. (1963) The glucose fatty acid cycle and its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1, 785\u2013789.","DOI":"10.1016\/S0140-6736(63)91500-9"},{"key":"key\n\t\t\t\t20170410034031_REBUFFE-SCRIVE-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Rebuffe-Scrive, M., Cullberg, G., Lundberg, P.A. et al. (1989) Anthropometric variables and metabolism in polycystic ovarian disease. Horm. Metab. Res., 21, 391\u2013397.","DOI":"10.1055\/s-2007-1009245"},{"key":"key\n\t\t\t\t20170410034031_ROBERT-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Robert, Y., Dubrulle, F., Gaillandre, L. et al. (1995) Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized qualification. Fertil. Steril., 64, 307\u2013312.","DOI":"10.1016\/S0015-0282(16)57728-0"},{"key":"key\n\t\t\t\t20170410034031_ROBINSON-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Robinson, S., Kiddy, D., Gelding, S.V. et al. (1993) The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin. Endocrinol., 39, 351\u2013355.","DOI":"10.1111\/j.1365-2265.1993.tb02376.x"},{"key":"key\n\t\t\t\t20170410034031_RODIN-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Rodin, A., Thakkar, H., Taylor, N. et al. (1994) Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase [see comments]. N. Engl. J. Med., 330, 460\u2013465.","DOI":"10.1056\/NEJM199402173300703"},{"key":"key\n\t\t\t\t20170410034031_SHUSTER-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Shuster, L.T., Go, V.L., Rizza, R.A. et al. (1988) Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes, 37, 200\u2013203.","DOI":"10.2337\/diab.37.2.200"},{"key":"key\n\t\t\t\t20170410034031_STEWARD-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Steward, P.M., Boulton, A., Kumar, S. et al. (1999) Cortisol metabolism in human obesity: impaired cortisone\u2013cortisol conversion in subjects with central adiposity. J. Clin. Endocrinol. Metab., 84, 1022\u20131027.","DOI":"10.1210\/jc.84.3.1022"},{"key":"key\n\t\t\t\t20170410034031_WALDHAUSL-ETAL-1986","doi-asserted-by":"crossref","unstructured":"Waldhausl, W.K., Bratusch-Marrain, P., Gasic, S. et al. (1986) Inhibition by proinsulin of endogenous C-peptide release in healthy man. Am. J. Physiol., 251, E139\u2013145.","DOI":"10.1152\/ajpendo.1986.251.2.E139"},{"key":"key\n\t\t\t\t20170410034031_WAREHAM-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Wareham, N.J., Phillips, D.I., Byrne, C.D. et al. (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion [letter; comment]. Diabet. Med., 12, 931.","DOI":"10.1111\/j.1464-5491.1995.tb00399.x"},{"key":"key\n\t\t\t\t20170410034031_ZHANG-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Zhang, L.H., Rodriguez, H., Ohno, S. et al. (1995) Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc. Natl Acad. Sci. USA, 92, 10619\u201310623.","DOI":"10.1073\/pnas.92.23.10619"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:21:00Z","timestamp":1583310060000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/15.6.1266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2000,6]]},"published-print":{"date-parts":[[2000,6]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/15.6.1266","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}